324 related articles for article (PubMed ID: 29996062)
1. Anticancer therapy and lung injury: molecular mechanisms.
Li L; Mok H; Jhaveri P; Bonnen MD; Sikora AG; Eissa NT; Komaki RU; Ghebre YT
Expert Rev Anticancer Ther; 2018 Oct; 18(10):1041-1057. PubMed ID: 29996062
[TBL] [Abstract][Full Text] [Related]
2. [Chemoradiation Therapy].
Akimoto T
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1137-40. PubMed ID: 26489541
[TBL] [Abstract][Full Text] [Related]
3. Radiation-Induced Lung Injury: Assessment and Management.
Hanania AN; Mainwaring W; Ghebre YT; Hanania NA; Ludwig M
Chest; 2019 Jul; 156(1):150-162. PubMed ID: 30998908
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced lung injury: current evidence.
Arroyo-Hernández M; Maldonado F; Lozano-Ruiz F; Muñoz-Montaño W; Nuñez-Baez M; Arrieta O
BMC Pulm Med; 2021 Jan; 21(1):9. PubMed ID: 33407290
[TBL] [Abstract][Full Text] [Related]
5. Lung injury following acute kidney injury: kidney-lung crosstalk.
Doi K; Ishizu T; Fujita T; Noiri E
Clin Exp Nephrol; 2011 Aug; 15(4):464-70. PubMed ID: 21629995
[TBL] [Abstract][Full Text] [Related]
6. Renal and pulmonary late effects of cancer therapy.
Skinner R; Kaplan R; Nathan PC
Semin Oncol; 2013 Dec; 40(6):757-73. PubMed ID: 24331195
[TBL] [Abstract][Full Text] [Related]
7. The Time Course of Radiation-induced Lung Injury in a Nonhuman Primate Model of Partial-body Irradiation With Minimal Bone Marrow Sparing: Clinical and Radiographic Evidence and the Effect of Neupogen Administration.
MacVittie TJ; Farese AM; Parker GA; Jackson W
Health Phys; 2019 Mar; 116(3):366-382. PubMed ID: 30624350
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced and chemotherapy-induced pulmonary injury.
Abid SH; Malhotra V; Perry MC
Curr Opin Oncol; 2001 Jul; 13(4):242-8. PubMed ID: 11429481
[TBL] [Abstract][Full Text] [Related]
9. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Faivre-Finn C; Snee M; Ashcroft L; Appel W; Barlesi F; Bhatnagar A; Bezjak A; Cardenal F; Fournel P; Harden S; Le Pechoux C; McMenemin R; Mohammed N; O'Brien M; Pantarotto J; Surmont V; Van Meerbeeck JP; Woll PJ; Lorigan P; Blackhall F;
Lancet Oncol; 2017 Aug; 18(8):1116-1125. PubMed ID: 28642008
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy: emerging treatment improvement strategies.
Milas L; Mason KA; Liao Z; Ang KK
Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
Reboul FL
Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
[TBL] [Abstract][Full Text] [Related]
12. Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.
Kwint M; Uyterlinde W; Nijkamp J; Chen C; de Bois J; Sonke JJ; van den Heuvel M; Knegjens J; van Herk M; Belderbos J
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e223-8. PubMed ID: 22560551
[TBL] [Abstract][Full Text] [Related]
13. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
14. TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury.
Yang HZ; Wang JP; Mi S; Liu HZ; Cui B; Yan HM; Yan J; Li Z; Liu H; Hua F; Lu W; Hu ZW
Am J Pathol; 2012 Jan; 180(1):275-92. PubMed ID: 22062220
[TBL] [Abstract][Full Text] [Related]
15. Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer.
Verma V; Simone CB; Werner-Wasik M
Cancers (Basel); 2017 Sep; 9(9):. PubMed ID: 28885561
[TBL] [Abstract][Full Text] [Related]
16. Radiation and third-generation chemotherapy.
Chen Y; Okunieff P
Hematol Oncol Clin North Am; 2004 Feb; 18(1):55-80. PubMed ID: 15005281
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary injury associated with radiation therapy - Assessment, complications and therapeutic targets.
Rajan Radha R; Chandrasekharan G
Biomed Pharmacother; 2017 May; 89():1092-1104. PubMed ID: 28298070
[TBL] [Abstract][Full Text] [Related]
18. [Research progress on macrophage in radiation induced lung injury].
Li M; Liu P; Ke Y; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 49(5):623-628. PubMed ID: 33210491
[TBL] [Abstract][Full Text] [Related]
19. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.
Makishima H; Ishikawa H; Terunuma T; Hashimoto T; Yamanashi K; Sekiguchi T; Mizumoto M; Okumura T; Sakae T; Sakurai H
J Radiat Res; 2015 May; 56(3):568-76. PubMed ID: 25755255
[TBL] [Abstract][Full Text] [Related]
20. Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.
Barney CL; Scoville N; Allan E; Ayan A; DiCostanzo D; Haglund KE; Grecula J; Williams T; Xu-Welliver M; Otterson GA; Bazan JG
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):748-755. PubMed ID: 29413286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
